WE CAN HELP YOU FIND A DPP!!

Dear Member,

The landscape of UK community pharmacy is undergoing a fundamental and permanent shift. As we bridge the gap between the end of the 2025 Pathfinder pilots and the upcoming National Framework consultation in April, the direction of travel is absolute; community pharmacy is becoming a prescribing-led service. We understand that transitioning from a dispensing-focused model to a clinical prescribing model is a heavy operational lift. However, with the structural changes happening this year, adapting is no longer optional for those who wish to remain viable and competitive.

Here is a concise operational briefing on the current transition and what it means for your practice.

1. The Direction of Travel: The September 2026 Influx

Starting in September 2026, all newly registered pharmacists will enter the workforce as "Day 1" Independent Prescribers (IPs).

• The Reality: The market value of non-prescribing pharmacists will inevitably shift. Existing pharmacists must prioritize IP training now to maintain clinical parity and leadership within their teams.
• The Opportunity: Pharmacies that upskill their existing workforce will be positioned to capture the new tiered clinical services (e.g., expanded Pharmacy First, CVD management) expected in the 2026/27 Contractual Framework.

2. Legislative Enablers Are Now Live

To make prescribing operationally feasible, supervision rules have changed.

• As of January 7, 2026, the "Absent Authorisation" rule allows pharmacists to authorize senior technicians to hand out checked medicines during a pharmacist's temporary absence.
• Action: Implement this workflow immediately. You must decouple your pharmacists from the dispensary bench to create the protected time required for clinical consultations and prescribing training.

3. Strategic Imperatives for All Members

To prepare for the national rollout, we strongly advise completing the following steps by the end of Q2:

• Enroll in IP Training: If you or your pharmacists are not yet IPs, secure university placements and identify a Designated Prescribing Practitioner (DPP) immediately.
• Define Your Scope of Practice: Independent prescribing is not open-ended. Pharmacists must define and document their specific clinical scope (e.g., acute minor illness, hypertension) to ensure safe, governed practice.
• Audit Liability and Infrastructure: Review your Professional Indemnity (PI) insurance to ensure it explicitly covers Independent Prescribing. Additionally, verify with your PMR supplier that your system is on track for "Write Access" to patient records, which is critical for direct prescribing.

The transition from dispensing accuracy to clinical judgement carries new risks, but it also secures the long-term future of our profession. We must prepare our workforce today for the operational realities of tomorrow.

If you have any questions or need support please get in touch with us as usual on

 info@pharmaplusltd.co.uk and we will be happy to assist.

Regards,

PharmaPlus